Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition

Not available.

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-09-10
DOI
https://doi.org/10.3324/haematol.2026.301552
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition

闫淯淳, 钟笛箫, Qinlong Zheng, Zeliang Song et al.
Haematologica
Histiocytic Disorders and Treatments
article

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition

闫淯淳, 钟笛箫, Qinlong Zheng, Zeliang Song, Duanfang Shao, Juanjuan Li, Rong Liu, Jing Cao, Mei Yue, Mengze Hu, Tao Hu, Lei Zhang, Mengna Zhai
article en

Abstract

No abstract available for this paper.

Haematologica
Capital Institute of Pediatrics (CN), Children's Hospital of Capital Institute of Pediatrics (CN), Beijing Fengtai Hospital (CN)
Good health and well-being
Openalex Percentile: Top 11%
Histiocytic Disorders and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.